toggle navigation
Accueil
Professionnels
Etudes
Publications
Formation
Bourses et prix
Prestations
Fil infos
Patients
Adhérer à P&R
Notes médicales
Newsletters
Témoignages
Fil infos
Public
Notes médicales
Newsletters
Fil infos
Association P&R
Entreprises
Prestations
Newsletters
Fil infos
Fil infos
Contact
je fais un don
Fil infos d'ACTION-Coeur
INFORMATIONS COVID
Actualités
Congrès
Presse
Journées coeur
Dans la littérature
+
01/02/2008
Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial.
Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervent...
En savoir plus
+
07/09/2007
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention....
En savoir plus
+
24/01/2007
Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients’ data with long-term follow-up.
Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on in...
En savoir plus
+
05/09/2006
A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial.
A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute co...
En savoir plus
+
15/04/2003
Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study).
Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated hepa...
En savoir plus
+
21/06/2001
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction....
En savoir plus
Prec.
1
…
29
30
Suiv.